Managed care organization and the quality of diabetes care: The Translating Research into Action for Diabetes (TRIAD) study

Diabetes Care

Volumn 27, Issue 7, 2004, Pages 1529-1534

  Kim, Catherine ^a,b,i   Williamson, David F ^c   Mangione, Carol M ^d   Safford, Monika M ^e   Selby, Joseph V ^f   Marrero, David G ^g   Curb, J David ^h   Thompson, Theodore J ^c   Narayan, K M Venkat ^c   Herman, William H ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^f DIVISION OF RESEARCH   (United States)

^g INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h PACIFIC HEALTH RESEARCH INSTITUTE   (United States)

ⁱ NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEMOGLOBIN A1C; INFLUENZA VACCINE; LIPID;

AGE; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DIABETES MELLITUS; EDUCATION; ETHNOLOGY; FOOT; GENDER; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH STATUS; HEALTH SURVEY; INCOME; INFLUENZA VACCINATION; MANAGED CARE ORGANIZATION; MEDICAL CARE; MEDICAL STAFF; PRACTICE GUIDELINE; PROFIT; RACE; RETINA; VACCINATION;

DIABETES MELLITUS; FEMALE; HUMANS; MALE; MANAGED CARE PROGRAMS; QUALITY ASSURANCE, HEALTH CARE; TREATMENT OUTCOME; UNITED STATES;

EID: 3042716848     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.7.1529     Document Type: Article

References (35)

1. Fleming B, Greenfield S, Engelgau M, Pogach L, Clauser S, Parrott M: The Diabetes Quality Improvement Project: moving science into health policy to gain an edge on the diabetes epidemic. Diabetes Care 24:1815-1820, 2001
2. Saadine J, Engelgau M, Beckles G, Gregg E, Thompson T, Narayan K: A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med 136: 565-574, 2002
3. Meigs J, Stafford R: Cardiovascular disease prevention practices by U.S. physicians for patients with diabetes. J Gen Intern Med 15:220-228, 2000
4. Institute of Medicine: Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, D.C., National Academy Press, 2001
5. TRIAD Study Group: The Translating Research into Action for Diabetes (TRIAD) study: a multicenter study of diabetes in managed care. Diabetes Care 25:386-389, 2002
6. Ware J Jr, Kosinski M, Keller SD: A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220-233, 1996
7. Brazier J, Jones N, Kind P: Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual Life Res 2:169-180, 1993
8. Agency for Health Care Policy and Research: CAHPS 2.0 Survey and Reporting Kit. Rockville, MD, AHCPR, 1998
9. Peabody J, Luck J, Glassman P, Dresselhaus T, Lee M: Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. JAMA 283:1715-1722, 2000
10. Kerr E, Krein S, Vijan S, Hofer T, Hayward R: Avoiding pitfalls in chronic disease quality measurement: a case for the next generation of technical quality measures. Am J Manag Care 7:1033-1043, 2001
11. American Diabetes Association: Clinical practice recommendations 1999 (Position Statement). Diabetes Care 22 (Suppl. 1):S1-S114, 1999
12. S-PLUS. 6.1 ed. Seattle, WA, Insightful, 2002
13. Rothman K: No adjustments are needed for multiple comparisons. Epidemiology 1:43-46, 1990
14. Smith A, Bates M: Confidence limit analyses should replace power calculations in the interpretation of epidemiologic studies. Epidemiology 3:449-452, 1992
15. Charlson M, Pompei P, Ales K, MacKenzie C: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40: 373-383, 1987
16. The InterStudy Competitive Edge 13.2, Part I: HMO Directory. St. Paul, MN, Interstudy Publications, 2003
17. The Interstudy Competitive Edge 13.2, Part II: HMO Industry Report. St. Paul, MN, Interstudy Publications, 2003
18. Casalino L, Gillies R, Shortell S, Schmittdiel J, Bodenheimer T, Robinson J, Rundall T, Oswald N, Schauffler H, Wang M: External incentives, information technology, and organized processes to improve health care quality for patients with chronic diseases. JAMA 289:434-441, 2003
19. Shortell S, Jones R, Rademaker A, Gillies R, Dranove D, Hughes E, Budetti P, Reynolds K, Huang C: Assessing the impact of total quality management and organizational culture on multiple outcomes of care for coronary artery bypass graft surgery patients. Med Care 38:207-217, 2000
20. Shortell S, Zazzali J, Burns L, Alexander J, Gillies R, Budetti P, Waters T, Zuckerman H: Implementing evidence-based medicine: the role of market pressures, compensation incentives, and culture in physician organizations. Med Care 39 (7 Suppl. 1):162-178, 2001
21. Brown AF, Gross AG, Gutierrez PR, Jiang L, Shapiro MF, Mangione CM: Incomerelated differences in the use of evidence-based therapies on older persons with diabetes mellitus in for-profit managed care. J Am Geriatr Soc 51:665-670, 2003
22. Hargraves JL, Cunningham PJ, Hughes RG: Racial and ethnic differences in access to medical care in managed care plans. Health Serv Res 36:853-868, 2001
23. DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
24. American Diabetes Association: Aspirin therapy in diabetes (Position Statement). Diabetes Care 24 (Suppl. 1):S62-S63, 2001
25. American Diabetes Association: Aspirin therapy in diabetes (Position Statement). Diabetes Care 23 (Suppl. 1):S61-62, 2000
26. Colwell J: Aspirin for primary prevention of cardiovascular events in diabetes (Editorial). Diabetes Care 26:3349-3350, 2003
27. Chew E, Klein M, Murphy R, Remaley N, Ferris F: Effects of aspirin on vitreous/preretinal hemorrhage in patients with diabetes mellitus: Early Treatment Diabetic Retinopathy Study report no. 20. Arch Opthalmol 113:52-55, 1995
28. Himmelstein D, Woolhandler S, Hellander I, Wolfe S: Quality of care in investor-owned vs. not-for-profit HMOs. JAMA 282:159-163, 1999
29. Born P, Simon C: Patients and profits: the relationship between HMO financial performance and quality of care. Health Aff (Millwood) 20:167-174, 2001
30. Ware JJ, Bayliss M, Rogers W, Kosinsky M, Tarlov A: Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems: results from the Medical Outcomes Study. JAMA 276: 1039-1047, 1996
31. Tu H, Reschovsky J: Assessments of medical care by enrollees in for-profit and nonprofit health maintenance organizations. N Engl J Med 346:1288-1293, 2002
32. McCormick D, Himmelstein D, Woolhandler S, Wolfe S, Bor D: Relationship between low quality-of-care scores and HMOs' subsequent public disclosure of quality-of-care scores. JAMA 288:1484-1490, 2002
33. Blustein J, Hoy E: Who is enrolled in for-profit vs. nonprofit Medicare HMOs? Health Aff (Millwood) 19:210-220, 2000
34. Safran D, Rogers W, Tarlov A, Inui T, Taira D, Montgomery J, Ware J, Slavin C: Organization and financial characteristics of health plans: are they related to primary care performance. Arch Intern Med 160: 69-76, 2000
35. Vijan S, Hofer T, Hayward R: Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA 283:889-896, 2000